Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We investigated the prevalence of sarcopenic obesity (SO) and its relationship with metabolic syndrome in a community-based elderly cohort in Korea. RESEARCH DESIGN AND METHODS: In this study, 287 men and 278 women aged 65 or older were recruited. Sarcopenia was defined as the appendicular skeletal muscle mass (ASM) divided by height squared (Ht2) (kg/m2) or by weight (Wt) (%) of <1 SD below the sex-specific mean for young adults. Obesity was defined as a visceral fat area ≥100 cm2. RESULTS: The prevalence of SO was 16.7% in men and 5.7% in women with sarcopenia defined by ASM/Ht2; however, it was 35.1% in men and 48.1% in women by ASM/Wt. Using ASM/Wt, the homeostasis model assessment of insulin resistance of subjects with SO was higher and they were at higher risk for metabolic syndrome (odds ratio [OR] 8.28 [95% CI 4.45–15.40]) than the obese (5.51 [2.81–10.80]) or sarcopenic group (2.64 [1.08–6.44]). CONCLUSIONS: SO defined by ASM/Wt was more closely associated with metabolic syndrome than either sarcopenia or obesity alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most clinical studies have reported that sarcopenic obesity is associated with metabolic syndrome [136,137,138].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lim et al. observed a higher risk of metabolic syndrome among adults with sarcopenic obesity [defined using DXA-measured ALM/weight (%) and visceral fat area] [odds ratio (OR): 8.28, 95% CI: 4.45–15.40] than among those with obesity (OR: 5.51, 95% CI: 2.81–10.80) or sarcopenia (OR: 2.64, 95% CI: 1.08–6.44) in a cross-sectional study of 565 participants aged ≥65 years from the Korean Longitudinal”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“In contrast, using the definition ALM/ht2, the ORs of metabolic syndrome were lower in the obesity group than in the sarcopenic obesity group (2.90 [95% CI: 1.28–6.57] vs. 4.80 [95% CI: 2.63–8.75]) (89).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“Regarding body FM, the upper sex-specific cut-offs of 40% for females and 30% for males have been proposed as best predictors of mortality in the NHANES sample (American population) using DXA [59].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“(4) and 2) ASM as a percentage of body weight (ASM/Wt), which was modified from the study of Janssen et al.”
MethodJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Second, previous studies used BMI or the percentage of fat mass for the definition of obesity to obtain a sufficient number of subjects within the group for statistical analysis (14).”
MethodSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 1×
“(1) showed that the prevalence of metabolic syndrome was highest in the group of nonsarcopenic obese subjects.”
BackgroundNew Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“These factors activate a vicious cycle leading to accelerated sarcopenia, additional weight gain largely in the form of fat, and ultimately to physical disability (1, 9-12).”
Background
Research works printed but not linked: 1
- World Health Organization Western Pacific Region, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
Cited by
Items 201–300 of 593
New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia
Moon, J. J., Park, S., Ryu, S. M., & Park, C. H. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.1.15 · Cited by 41
“Based on such, Lim et al.[15] determined the value of the skeletal muscle mass index (SMI; ASM [kg]/body weight [kg]×100) (%) by dividing the ASM measured using DXA by the weight for sarcopenia diagnosis.”
MethodInfluentialMuscle Strength Is Independently Related to Brain Atrophy in Patients with Alzheimer’s Disease
Moon, Y., Moon, W., Kim, J. O., Kwon, K., & Han, S.-H. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000500718 · Cited by 38
Self-citationKim, B. C., Kim, M. K., Han, K., Lee, S.-Y., Lee, S., Ko, S., Kwon, H., Merchant, A. T., Yim, H. W., Lee, W., et al. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.09.020 · Cited by 43
“We defined ASM as a percentage of body weight (ASM divided by weight [ASM/Wt]), as modified from the studies of Janssen et al [19] and Lim et al [10].”
BackgroundMethodInfluentialSelf-citationHwang, Y., Cho, I.-J., Jeong, I., Ahn, K. J., & Chung, H. Y. (2016) · Obesity · doi:10.1002/oby.21694 · Cited by 39
Pal, R., Bhadada, S. K., Aggarwal, A., & Singh, T. (2021) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2020.12.003 · Cited by 43
“Besides, SO also contributes to insulin resistance with the resultant increase in the risk of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) [8,9].”
BackgroundInfluentialJung, M., Ihm, S., Park, S. M., Jung, H. O., Hong, K.-S., Baek, S. H., & Youn, H. (2019) · Metabolism · doi:10.1016/j.metabol.2019.05.007 · Cited by 37
Chang, K. C., Yang, K., Wu, W., Huang, K., & Han, D. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s219649 · Cited by 37
“visceral fat, known as sarcopenic obesity, were eight-times more likely to developMetS comparedwith those with obesity or sarcopenia alone.(9) A computed tomography study found a negative correlation between waist circumference and muscle density of the forearm and calf in a cohort of patients with MetS.”
BackgroundSarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
Seo, D. H., Lee, Y., Park, S. W., Choi, Y. J., Huh, B. W., Lee, E. J., Huh, K. B., Kim, S. H., & Cha, B.-S. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.004 · Cited by 41
Kim, B., Ahn, S. H., Kim, H. M., Lee, S. H., & Koh, J. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2959-z · Cited by 38
“Therefore, we additionally performed multiple regression analyses with employing ASM/height2 as the independent variable as well.”
ResultInfluentialPolycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study
McBreairty, L. E., Chilibeck, P. D., Gordon, J. J., Chizen, D. R., & Zello, G. A. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0381-4 · Cited by 36
Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes
Seo, D. H., Lee, Y., Suh, Y. J., Ahn, S. H., Hong, S., Choi, Y. J., Huh, B. W., Park, S. W., Lee, E. J., & Kim, S. H. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.05.021 · Cited by 37
The interplay between muscle mass decline, obesity, and type 2 diabetes
Maliszewska, K., Adamska-Patruno, E., & Kretowski, A. J. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15025 · Cited by 41
How to Diagnose Sarcopenia in Korean Older Adults?
Jang, H. C., & the Sarcopenia Study Group of Korean Geriatrics Society (2018) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.2018.22.2.73 · Cited by 37
Self-citationKim, S. H., Kang, H. W., Jeong, J. B., Lee, D. S., Ahn, D., Kim, J. W., Kim, B. G., Lee, K. L., Oh, S., Yoon, S. H., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256083 · Cited by 39
Self-citationMoon, J. H., Choo, S. R., & Kim, J. S. (2015) · Journal of Bone Metabolism · doi:10.11005/jbm.2015.22.3.99 · Cited by 38
Self-citationJo, Y., Linton, J. A., Choi, J., Moon, J., Kim, J., Lee, J., & Oh, S. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.17.0078 · Cited by 33
Self-citationHong, J.-Y., Park, K.-Y., Kim, B.-J., Hwang, W.-M., Kim, D.-H., & Lim, D.-M. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.80 · Cited by 32
Self-citationRecent Advances in Nutraceuticals for the Treatment of Sarcopenic Obesity
Kim, Y.-C., Ki, S.-W., Kim, H., Kang, S., Kim, H., & Go, G. (2023) · Nutrients · doi:10.3390/nu15173854 · Cited by 35
“Therefore, SO may have a greater impact on the metabolic syndrome (MetS) and may be associated with mortality rates, including T2DM, nonalcoholic fatty liver disease (NAFLD), dyslipidemia, hypertension, and cardiovascular disease (CVD), than sarcopenia or obesity alone [52].”
BackgroundSelf-citationNonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.016 · Cited by 32
Kwon, I., Kim, J., Shin, C., Park, Y., & Kim, J.-H. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0023 · Cited by 36
Self-citationDefinition of Sarcopenia in Chronic Liver Disease
Son, S. W., Song, D. S., Chang, U. I., & Yang, J. M. (2021) · Life · doi:10.3390/life11040349 · Cited by 36
“The ASMI is positively correlated with BMI, visceral fat, and insulin resistance, while weight-adjusted or BMI-adjusted sarcopenia indices are negatively correlated in obese subjects [17,69].”
BackgroundBiological Markers in Older People at Risk of Mobility Limitations
Lippi, G., Sanchis‐Gomar, F., & Montagnana, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660697 · Cited by 33
“Insulin resistance has been for long considered a contributing factor to age-related muscle mass loss, which further leads to decline in muscle strength [56-58].”
BackgroundImpact of sarcopenic overweight on the outcomes after living donor liver transplantation
Hammad, A., Kaido, T., Hamaguchi, Y., Okumura, S., Kobayashi, A., Shirai, H., Kamo, N., Yagi, S., & Üemoto, S. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.02.02 · Cited by 32
“(32) reported that psoas muscle thickness on CT imaging at the level of the umbilicus divided by height might be predictive of mortality, as it might be difficult to precisely identify a given lumbar section because of sacralization of the L5 vertebrae, lumbar wedge fractures, and more pronounced lordosis in patients…”
BackgroundHong, S.-Y. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.1.53 · Cited by 34
Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women
Lee, J., Kim, J., & Lee, D. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318291f6c8 · Cited by 33
Self-citationNonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
“Janssen and coworkers proposed weight-adjusted muscle mass index (SM/wt), which is suggested to be the more appropriate index for obese patients [51].”
BackgroundMai, Z., Chen, Y., Mao, H., & Wang, L. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13569 · Cited by 34
“32,33 Loss of skeletal muscle mass is associated with insulin resistance and diabetes, which are also linked to NAFLD.”
BackgroundChung, T., Kwon, Y., Shim, J., & Lee, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.032 · Cited by 32
A bibliometric analysis of sarcopenia: top 100 articles
Suzan, V., & Suzan, A. A. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00395-y · Cited by 32
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00915-2 · Cited by 30
“Among Korean subjects aged 65 or older, IR was higher in the obese group with relatively low muscle mass than in the obese group without low muscle mass [19].”
BackgroundAssociation between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
Song, W., Yoo, S. H., Jang, J., Baik, S. J., Lee, B. K., Lee, H. W., & Park, J. S. (2022) · Gut and Liver · doi:10.5009/gnl220041 · Cited by 33
“12,13 The threshold of sarcopenia was 30.0% for males and 26.8% for females.”
InfluentialShishikura, K., Tanimoto, K., Sakai, S., Tanimoto, Y., Terasaki, J., & Hanafusa, T. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0375 · Cited by 30
“The muscle mass data were used to calculate appendicular muscle mass (AMM) as the sum of the muscle mass of the arms and the legs and the skeletal muscle index (SMI) as the ratio of AMM to total body weight expressed as a percentage value [10, 11].”
MethodSarcopenic obesity predicts nonremission of late‐life depression
Kokkeler, K. J. E., van den Berg, K. S., Comijs, H. C., Voshaar, R. C. O., & Marijnissen, R. M. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5121 · Cited by 32
“Skeletal muscle mass widely differs between obese persons, and low muscle mass is associated with specific health risks.(8,15) Sarcopenic obesity has been associated with metabolic and functional impairments as well as increased mortality rates.”
BackgroundInfluentialde Campos, G. C., Lourenço, R. A., & Lopes, C. D. S. (2020) · Clinics · doi:10.6061/clinics/2020/e1814 · Cited by 33
Validity of muscle-to-fat ratio as a predictor of adult metabolic syndrome
Park, J.-S., & Kim, S. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.1036 · Cited by 31
Choe, E. Y., Lee, Y., Choi, Y. J., Huh, B. W., Lee, B., Kim, S., Kang, E. S., Cha, B., Lee, E. J., Huh, K. B., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14011 · Cited by 28
Kang, M. K., Park, J. G., Lee, H. J., & Kim, M. C. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14607 · Cited by 28
Okamura, T., Hashimoto, Y., Osaka, T., Fukuda, T., Hamaguchi, M., & Fukui, M. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-114 · Cited by 29
Sugimura, Y., Kanda, A., Sawada, K., Wai, K. M., Tanabu, A., Ozato, N., Midorikawa, T., Hisada, T., Nakaji, S., & Ihara, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127464 · Cited by 32
“ASM/BW was used as the skeletal muscle index [3,16].”
BackgroundMethodXu, K., Zhu, H. J., Chen, S., Chen, L., Wang, X., Zhang, L., Pan, L., Wang, L., Feng, K., Wang, K., et al. (2018) · PubMed · doi:10.3967/bes2018.034 · Cited by 33
Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification
Jun, J. E., Kang, M., Jin, S.-M., Kim, K., Hwang, Y.-C., Jeong, I.-K., & Kim, J. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0885 · Cited by 27
Self-citationCho, Y. K., Jung, H. N., Kim, E. H., Lee, M. J., Park, J., Lee, W. J., Kim, H., & Jung, C. H. (2023) · Obesity · doi:10.1002/oby.23733 · Cited by 28
“Furthermore, most clinical studies have revealed that sarcopenic obesity is associated with metabolic syndrome [28], type 2 diabetes mellitus [29], nonalcoholic fatty liver disease [30, 31], heart failure [32], cardiovascular disease [33], and, finally, mortality [34].”
BackgroundBoyajian, J. L., Islam, P., Abosalha, A. K., Schaly, S., Thareja, R., Kassab, A., Arora, K., Santos, M., Shum-Tim, C., & Prakash, S. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.05 · Cited by 30
Hong, N., Lee, E. Y., & Kim, C. O. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0119 · Cited by 27
“We used weight-adjusted ASM (ASM/Wt) to define sarcopenia based on previous studies that suggested that ASM/Wt might be a more appropriate method of defining sarcopenia and sarcopenic obesity than height-adjusted ASM (ASM/Ht2) because of better correlations with insulin resistance and abdominal obesity [7, 9].”
BackgroundMethodResultInfluentialObesity and Metabolic Health in CKD
Kovesdy, C. P. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000704 · Cited by 31
“32 In populations with CKD, studying sarcopenic obesity is even more complicated.”
Fukuda, T., Bouchi, R., Asakawa, M., Takeuchi, T., Shiba, K., Tsujimoto, K., Komiya, C., Yoshimoto, T., Ogawa, Y., & Yamada, T. (2019) · Diabetic Medicine · doi:10.1111/dme.14153 · Cited by 26
Zhang, X., He, Z., Si, Q., Hu, X., Yang, L., Gu, X., Du, L.-J., Wang, L., Pan, L., Li, Y., et al. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2229139 · Cited by 27
Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes
Moon, J. S., Lee, J. E., & Yoon, J. S. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.3.207 · Cited by 26
Self-citationKim, J. A., Hwang, S. Y., Chung, H. S., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Baik, S. H., & Yoo, H. J. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0036 · Cited by 29
Self-citationKim, T. N., Won, J. C., Kim, Y. J., Lee, E. J., Kim, M.-K., Park, M. S., Lee, S. K., Kim, J. M., Ko, K. S., & Rhee, B. D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.05.014 · Cited by 28
Self-citationChung, S., Hyun, M. H., Lee, E., & Seo, H. S. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3548-0 · Cited by 26
Wang, J., Zeng, L., Hong, C., Cui, H., Wang, W., Zhu, H., Li, Q., Li, Y., Li, R., He, J., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14990 · Cited by 28
“7,26,27 Thus, sarcopenia may lead to MASLD via insulin resistance.”
BackgroundCurrent Status of Sarcopenia in Korea: A Focus on Korean Geripausal Women
Park, H. M. (2018) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.2018.22.2.52 · Cited by 26
Jun, J. E., Choi, M. S., Park, S. W., Kim, G., Jin, S., Kim, K., Hwang, Y., Ahn, K. J., Chung, H. Y., Jeong, I., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.04.002 · Cited by 25
Self-citationTreating morbid obesity in cirrhosis: A quest of holy grail
Kumar, N., & Choudhary, N. S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2819 · Cited by 27
Ribeiro, I. S., Pereira, Í. S., dos Santos, D. P., Lopes, D. N., Prado, A. O., Calado, S. P. D. M., Gonçalves, C. V., Galantini, M. P. L., Muniz, I. P. R., dos Santos, G. G. A., et al. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110734 · Cited by 25
Yoo, S., Kim, D., & Lim, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02179-3 · Cited by 25
Song, P., Han, P., Zhao, Y., Zhang, Y., Wang, L., Tao, Z., Jiang, Z., Shen, S., Wu, Y., Wu, J., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02143-8 · Cited by 28
“In our study, we used weight adjusted ASM as it has been shown to be more closely related to MetS and its parameters than ASM/height2 [30], and a stronger association between weight adjusted ASM and MetS has been reported [8, 27].”
MethodPartially Hydrolyzed Guar Gum Suppresses the Development of Sarcopenic Obesity
Okamura, T., Hamaguchi, M., Mori, J., Yamaguchi, M., Mizushima, K., Abe, A., Ozeki, M., Sasano, R., Naito, Y., & Fukui, M. (2022) · Nutrients · doi:10.3390/nu14061157 · Cited by 29
“Muscle atrophy has also been reported to be a risk factor for decreased activities of daily living and mortality [6,7]; in particular, sarcopenic obesity has been reported to accelerate the loss of muscle mass and function, reduce physical performance, and increase the risk of death [8], but no effective treatment has…”
BackgroundPark, C., Do, J. G., Lee, Y., & Yoon, K. J. (2022) · Medicina · doi:10.3390/medicina58101361 · Cited by 25
“demonstrated that sarcopenic obesity determined by weight-adjusted SMI is more closely associated with metabolic syndrome than height-adjusted SMI in a longitudinal study [52].”
BackgroundMagnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective
Yu, B. C.-Y., Kwok, D., & Wong, V. W. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.01.007 · Cited by 27
“It would be highly beneficial as dietary nutritional management is an important component in preventing and treating NAFLD.10,13”
BackgroundInfluentialKhadra, D., Itani, L., Chebaro, Y., Obeid, M., Jaber, M., Ghanem, R., Ayton, A. K., Kreidieh, D., Masri, D. E., Kimura, A., et al. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16666200214104122 · Cited by 24
“metabolic and cardiovascular diseases) [5, 6, 8-15], with the speculation that the two components of SO, namely the increase of fat deposition and the reduction in muscle mass and strength, seem to act synergistically to increase the adverse consequences on health, but this hypothesis has not been confirmed [16-18].”
BackgroundAgeing, adiposity indexes and low muscle mass in a clinical sample of overweight and obese women
Siervo, M., Stephan, B. C. M., Nasti, G., & Colantuoni, A. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.05.001 · Cited by 27
“Sarcopenic obesity has been associated with functional impairment, physical disability, increased length of hospital stay and reduced survival [4—8].”
BackgroundSarcopenia as the Mobility Phenotype of Aging: Clinical Implications
Ji, S., Jung, H., Baek, J. Y., Jang, I., & Lee, E. (2024) · Journal of Bone Metabolism · doi:10.11005/jbm.2024.31.1.1 · Cited by 27
“[22,23] When conducting longitudinal observations in community-dwelling older individuals, sarcopenia has been re-ported to be associated with various adverse outcomes, including overall mortality, falls, fractures, physical and cognitive function decline, impairment of activities of daily living,…”
Kim, Y., Joh, J., Kim, S., Hwang, H., & Shin, I. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-144 · Cited by 27
“27 kg/m(2) in women, while a study in Taiwan used the lower 20 percentile values of gender specific healthy young age individuals [22,23,25].”
BackgroundKoo, H. S., Kim, M. J., Kim, K., & Kim, Y. (2014) · Clinical Endocrinology · doi:10.1111/cen.12509 · Cited by 26
Self-citationMo, Y., Yang, C., Su, Y.-D., Dong, X., Deng, W., Liu, B., Yao, X., & Wang, X. (2021) · Age and Ageing · doi:10.1093/ageing/afab272 · Cited by 28
The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting
LORENZO, A. D., Pellegrini, M., Gualtieri, P., Itani, L., Ghoch, M. E., & Renzo, L. D. (2022) · Nutrients · doi:10.3390/nu14245295 · Cited by 25
Preserved Lower Limb Muscle Mass Prevents Insulin Resistance Development in Nondiabetic Older Adults
Seko, T., Akasaka, H., Koyama, M., Himuro, N., Saitoh, S., Miura, T., Mori, M., & Ohnishi, H. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.12.002 · Cited by 25
Cvijetić, S., Macan, J., Boschiero, D., & Ilich, J. Z. (2023) · Annals of Human Biology · doi:10.1080/03014460.2023.2180089 · Cited by 22
“Those findings were corroborated in our study, but with a different indicator - wSMI, which is a diagnostic parameter for sarcopenia and reflects the skeletal muscle mass of the extremities adjusted for weight (Lim et al. 2010).”
ResultRecent Progression in Sarcopenia and Sarcopenic Obesity
Jang, H. C., & MD, M. (2011) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2011.15.1.1 · Cited by 22
Self-citationShi, Y., Chen, X., Qiu, H.-N., Jiang, W.-R., Zhang, M., Huang, Y., Ji, Y.-P., Zhang, S., Li, C., & Lin, J. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1879244 · Cited by 22
“Parameters representative of adipose content such as body fat percentage, VFA and fat mass index were reported as risk factors for MetS and NAFLD [22,23].”
BackgroundMetabolic-Associated Fatty Liver Disease and Sarcopenia
Bali, T., Chrysavgis, L., & Cholongitas, Ε. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.02.004 · Cited by 22
Ou, Y.-C., Chuang, H.-H., Li, W.-C., Tzeng, I.-S., & Chen, J.-Y. (2017) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.04.006 · Cited by 15
“According to a previous study, ASM divided by weight (ASM/Wt) was more closely associated with MetS (Lim et al., 2010).”
MethodInfluentialSarcopenia in cancer survivors is associated with increased cardiovascular disease risk
Lee, S. J., Park, Y. J., & Cartmell, K. B. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4083-7 · Cited by 27
“defined as values less than 1 standard deviation of the reference group of 20–39 years old [22, 23].”
BackgroundSelf-citationMoon, J. H., Kong, M.-H., & Kim, H.-J. (2015) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2015.03.007 · Cited by 21
Peterson, M. D., Snih, S. A., Rexach, J. A. S., & Burant, C. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv002 · Cited by 23
“Indeed, sedentary aging adults are known to be at increased risk for weakness and sarcopenic obesity (12,13), which are in-turn primary drivers of musculoskeletal fragility (14–16), cardiometabolic abnormalities (17), and early all-cause mortality (18–20).”
BackgroundOh, C., Park, J. H., Chung, H. S., Yu, J. M., Chung, W., Kang, J. G., & Moon, S. (2020) · Medicine · doi:10.1097/md.0000000000022036 · Cited by 20
Chung, T., Shim, J., & Lee, Y. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.11.011 · Cited by 20
Jo, M. H., Lim, T. S., Jeon, M. Y., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K., & Kim, S. U. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030322 · Cited by 22
Kim, K. W., Baek, M., Yoon, M., & Son, K. H. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.009 · Cited by 20
Self-citationMuscle profile and cognition in patients with Alzheimer’s disease dementia
Moon, Y., Choi, Y., Kim, J. O., & Han, S. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3505-0 · Cited by 22
Self-citationUnderstanding the development of sarcopenic obesity
Gross, D. C., Cheever, C. R., & Batsis, J. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267672 · Cited by 21
Novel subgroups of obesity and their association with outcomes: a data-driven cluster analysis
Takeshita, S., Nishioka, Y., Tamaki, Y., Kamitani, F., Mohri, T., Nakajima, H., Kurematsu, Y., Okada, S., Myojin, T., Noda, T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-17648-1 · Cited by 19
Sarcopenic Obesity in Elderly Korean Women: A Nationwide Cross-sectional Study
Kwon, Y. N., Yoon, S. S., & Lee, K.-H. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.1.53 · Cited by 42
Association between CT-Measured Abdominal Skeletal Muscle Mass and Pulmonary Function
Choe, E. K., Lee, Y., Kang, H. Y., Choi, S. H., & Kim, J. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050667 · Cited by 19
“[13] was large, the authors used BIA, which is a less reliable method for quantifying body composition than CT in terms of accuracy, to observe the relationship between whole-body muscle and lung function [6,13].”
MethodSelf-citationAssociations of skeletal muscle mass with atherosclerosis and inflammatory markers in Korean adults
Yoon, S.-K., Kim, H., & Song, S.-W. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104163 · Cited by 19
Kang, M. K., & Park, J.-G. (2021) · Diagnostics · doi:10.3390/diagnostics11050854 · Cited by 22
“Considering that skeletal muscle is an insulin-sensitive organ, loss of skeletal muscle mass exacerbates IR and glycogenolysis, thereby leading to lipolysis in adipose tissue and excess free fatty acid (FFA) levels [35].”
BackgroundZhuang, M., Jin, M., Lu, T., Lu, L., Ainsworth, B. E., Liu, Y., & Chen, N. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.917525 · Cited by 18
“…et al., 2010)], Asia [AWGS-2013 (Chen et al., 2014)], the United States [FNIH (Studenski et al., 2014), Janssen (Janssen et al., 2002), Newman (Newman et al., 2003) and Fried (Fried et al., 2001)], Korea [Chung (Chung et al., 2013) and Lim (Lim et al., 2010)] and Japan [Kim (Kim et al., 2016)].”
BackgroundInfluentialAbe, S., Nozawa, H., Sasaki, K., Murono, K., Emoto, S., Yokoyama, Y., Matsuzaki, H., Nagai, Y., Yoshioka, Y., Shinagawa, T., et al. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.10.001 · Cited by 20
Sarcopenia, sarcopenic obesity, and arterial stiffness among older adults
Fantin, F., Giani, A., Manzato, G., Zampieri, A., Comellato, G., Urbani, S., Zoico, E., Mazzali, G., & Zamboni, M. M. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1272854 · Cited by 21
Dai, C., Sun, X., Wu, L., Chen, J., Xiao-hong, H., Ding, F., Chen, W., Lei, H., & Li, X. (2024) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-024-02072-0 · Cited by 18
“Studies suggest that sarcopenic obesity increases the likelihood of developing MetS (Lu et al. 2013; Lim et al. 2010).”
The effect of sarcopenic obesity on cardiovascular disease and all-cause mortality in older people
Atkins, J. L., & Wannamethee, S. G. (2015) · Reviews in Clinical Gerontology · doi:10.1017/s0959259815000076 · Cited by 18
Impact of sarcopenia on the risk of advanced colorectal neoplasia
Hong, J. T., Kim, T. J., Pyo, J. H., Kim, E. R., Hong, S. N., Kim, Y., Ahn, H. S., Sohn, I., & Chang, D. K. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14309 · Cited by 18
Moon, S. (2014) · Endocrine · doi:10.1007/s12020-013-0160-3 · Cited by 18
Body Composition, Sarcopenia, and Suicidal Ideation in Elderly Koreans: Hallym Aging Study
Kim, J. H., Kim, D.-H., & Park, Y. S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.4.604 · Cited by 18
“However, in previous studies conducted in South Korea, the height-adjusted definition showed a weak correlation with age-related muscle mass loss than the weight-adjusted definition, and the weight-adjusted definition was more closely correlated with health problems related to sarcopenia as compared with the height-ad…”
MethodResultSelf-citationOh, C., & No, J.-K. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.12.008 · Cited by 19
Lu, Z., Hu, Y., He, H., Chen, X., Ou, Q., Liu, Y., Xu, T., Tu, J., Li, A., Lin, B., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111783 · Cited by 17
Nutritional Considerations in Preventing Muscle Atrophy
Creţoiu, S. M., & Zugravu, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 19
Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study
Hashimoto, Y., Okamura, T., Hamaguchi, M., Obora, A., Kojima, T., & Fukui, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010227 · Cited by 18
Metadata
- Authors
- Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C.
- Affiliations
- Seoul National University (KR)
- Corresponding author
- Jang, Hak Chul
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-05-11
- Volume
- 33
- Issue
- 7
- Pages
- 1652-1654
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890376
- OpenAlex
- W2055418044
- Cited by
- 588
- References
- 17
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 43 · 2023: 38 · 2022: 48 · 2021: 50 · 2020: 41 · 2019: 50 · 2018: 48 · 2017: 35 · 2016: 50 · 2015: 50 · 2014: 31 · 2013: 26 · 2012: 23
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenic obesity, sarcopenia, obesity, metabolic syndrome, prevalence, older adults, appendicular skeletal muscle mass, visceral fat area, insulin resistance, sex differences
- MeSH terms
- Aged, Aged, 80 and over, Aging, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Obesity, Risk Factors, Prevalence, Logistic Models, Sex Distribution, Metabolic Syndrome, Asian People, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.